Neuroinvasion of SARS-CoV-2 in Human Brain Organoids and Mouse Models
Source Song et al., 2021 · Yale School of Medicine · 10.1084/jem.20202135
Abstract
This protocol establishes methods to investigate SARS-CoV-2 neuroinvasion using three complementary approaches: human brain organoids derived from induced pluripotent stem cells, transgenic mice expressing human ACE2, and postmortem analysis of COVID-19 patient brain tissue. The organoid model enables single-cell transcriptional profiling to characterize viral tropism, cellular metabolic changes, and neuronal death without robust interferon responses.
Protocol overview
71 steps across 12 phases
- 1 Culture human iPSC lines
- 2 Differentiate iPSCs to neural progenitor cells
- 3 Characterize NPCs by immunostaining
- 1 Prepare embryoid bodies
- 2 Generate cerebral organoids
- 3 Confirm dorsal cortical identity
- 1 Generate P1 viral stock
- 2 Generate working viral stock
- 3 Concentrate virus by PEG precipitation
- 4 Harvest and resuspend precipitated virus
- 5 Determine viral titer by plaque assay
- 1 Prepare organoids for infection
- 2 Infect organoids with SARS-CoV-2
- 3 Collect organoids at multiple time points
- 1 Prepare organoids for ACE2 blocking
- 2 Infect antibody-pretreated organoids
- 3 Prepare cerebrospinal fluid (CSF) from COVID-19 patient
- 4 Perform ELISA for anti-SARS-CoV-2 antibodies
- 5 Perform neutralization assay
- 1 Fix organoids in paraformaldehyde
- 2 Prepare cryostat sections
- 3 Block and permeabilize sections
- 4 Perform primary antibody staining
- 5 Perform TUNEL staining
- 6 Apply secondary antibodies and mount
- 7 Acquire confocal images
- 1 Prepare single-cell suspension
- 2 Load cells onto 10x Chromium
- 3 Prepare single-cell RNA-seq libraries
- 4 Sequence libraries on NovaSeq
- 5 Demultiplex and align reads
- 6 Generate count matrices and integrate samples
- 7 Perform dimensionality reduction and clustering
- 8 Annotate cell types
- 9 Identify infected cells
- 10 Perform differential expression analysis
- 1 Fix organoid tissue
- 2 Dehydrate tissue
- 3 Embed and section tissue
- 4 Image with transmission electron microscopy
- 1 Prepare transgenic mice
- 2 Perform intranasal SARS-CoV-2 infection
- 3 Collect brain tissue at defined time points
- 4 Quantify viral RNA by RT-qPCR
- 5 Determine viral titer by plaque assay
- 1 Prepare infected brains for iDISCO+
- 2 Perform dichloromethane and peroxide bleaching
- 3 Rehydrate and permeabilize brains
- 4 Block and immunostain with primary antibodies
- 5 Apply secondary antibodies
- 6 Clear brains and prepare for imaging
- 7 Perform light sheet microscopy imaging
- 8 Analyze viral distribution with ClearMap
- 1 Prepare AAV-hACE2 virus
- 2 Perform intratracheal AAV injection
- 3 Perform intracisternal magna AAV injection
- 4 Administer post-operative care
- 5 Allow AAV expression time
- 6 Perform intranasal SARS-CoV-2 infection of lung-hACE2 mice
- 7 Perform intraventricular SARS-CoV-2 infection of brain-hACE2 mice
- 8 Monitor weight and survival
- 1 Obtain human autopsy tissues
- 2 Prepare FFPE sections
- 3 Perform antigen retrieval
- 4 Stain with H&E
- 5 Block and permeabilize tissue sections
- 6 Perform primary antibody staining
- 7 Apply secondary antibodies
- 8 Quench lipofuscin autofluorescence
- 9 Mount and image sections
- 10 Perform immunohistochemistry for semiquantitative analysis
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Song et al., 2021. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol